|
|
1 - Background of the Course.mp4
|
MP4
|
95.8 MB
|
|
|
1 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
10 - Course Questions.html
|
HTML
|
3.9 KB
|
|
|
10 - Course-Questions-Coronavirus-Story.pdf
|
PDF
|
128.2 KB
|
|
|
10 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
100 - 5 Anticoagulants and COVID19 Biomarkers – Part Two.html
|
HTML
|
3.2 KB
|
|
|
100 - Anticoagulants-and-COVID-19-Biomarkers-2.pdf
|
PDF
|
138.9 KB
|
|
|
101 - 6 NSAIDs Usage in Covid19 Patients.mp4
|
MP4
|
22.4 MB
|
|
|
102 - 6 NSAIDs Usage in Covid19 Patients.html
|
HTML
|
1.6 KB
|
|
|
102 - NSAIDs-Usage-in-Covid-19-Patients-Coronavirus-story.pdf
|
PDF
|
125.3 KB
|
|
|
103 - 7 Bronchodilators Usage in Covid19 Patients.mp4
|
MP4
|
4 MB
|
|
|
104 - 7 Bronchodilators Usage in Covid19 Patients.html
|
HTML
|
1.1 KB
|
|
|
104 - Bronchodilators-Usage-in-Covid-19-Patients-Coronavirus-story.pdf
|
PDF
|
82.9 KB
|
|
|
105 - 8 Gastrointestinal Agents Usage in COVID19 Patients.mp4
|
MP4
|
6.4 MB
|
|
|
106 - 8 Gastrointestinal Agents Usage in COVID19 Patients.html
|
HTML
|
1.6 KB
|
|
|
106 - Gastrointestinal-Agents-Usage-in-COVID-19-Patients-Coronavirus-Story.pdf
|
PDF
|
125.3 KB
|
|
|
107 - 9 Antihypertensive Drugs Usage in COVID19 Patients.mp4
|
MP4
|
5.3 MB
|
|
|
108 - 9 Antihypertensive Drugs Usage in COVID19 Patients.html
|
HTML
|
2.2 KB
|
|
|
108 - Antihypertensive-Drugs-Usage-in-COVID-19-Patients-Coronavirus-Story.pdf
|
PDF
|
127.4 KB
|
|
|
109 - ECMO Machine HighFlow Oxygen Fluid management and Spirometer Use.mp4
|
MP4
|
78.9 MB
|
|
|
11 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
11 - Significance of the Course.mp4
|
MP4
|
24.8 MB
|
|
|
110 - ECMO Machine HighFlow Oxygen Fluid management and Spirometer Use.html
|
HTML
|
4.6 KB
|
|
|
110 - ECMO-Machine-High-Flow-Oxygen-Fluid-management-and-Spirometer-Use-Coronavirus-Story.pdf
|
PDF
|
132.7 KB
|
|
|
111 - Drug Repurposing A Prosperous Tactic.mp4
|
MP4
|
20.1 MB
|
|
|
112 - Drug Repurposing A Prosperous Tactic.html
|
HTML
|
4.6 KB
|
|
|
112 - Drug-Repurposing-Coronavirus-Story.pdf
|
PDF
|
145.7 KB
|
|
|
113 - The COVID19 Vaccine Scheme.mp4
|
MP4
|
54.7 MB
|
|
|
114 - The COVID19 Vaccine Scheme.html
|
HTML
|
2.8 KB
|
|
|
114 - The-COVID-19-Vaccine-Scheme-Coronavirus-Story.pdf
|
PDF
|
127.8 KB
|
|
|
115 - The Improvement of SARSCoV2 Vaccines.mp4
|
MP4
|
19 MB
|
|
|
116 - The Improvement of SARSCoV2 Vaccines.html
|
HTML
|
3.9 KB
|
|
|
116 - The-Improvement-of-SARS-CoV-2-Vaccines-Coronavirus-Story.pdf
|
PDF
|
134.4 KB
|
|
|
117 - Vaccine Platforms.mp4
|
MP4
|
13.5 MB
|
|
|
118 - Vaccine Platforms.html
|
HTML
|
4.3 KB
|
|
|
118 - Vaccine-Platforms-Coronavirus-Story.pdf
|
PDF
|
140.1 KB
|
|
|
119 - Summary.mp4
|
MP4
|
106.8 MB
|
|
|
12 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
12 - Significance of the Course.html
|
HTML
|
5.1 KB
|
|
|
12 - Significance-of-the-Course-Coronavirus-Story.pdf
|
PDF
|
130.1 KB
|
|
|
120 - Summary-Coronavirus-Story.pdf
|
PDF
|
138.9 KB
|
|
|
120 - Summary.html
|
HTML
|
4.4 KB
|
|
|
121 - Future Work and Recommendations.mp4
|
MP4
|
24.6 MB
|
|
|
122 - Future Work and Recommendations.html
|
HTML
|
4.8 KB
|
|
|
122 - Future-Work-and-Recommendations-Coronavirus-Story.pdf
|
PDF
|
88.3 KB
|
|
|
123 - Limitations.mp4
|
MP4
|
28.2 MB
|
|
|
124 - Limitations-Coronavirus-Story.pdf
|
PDF
|
138.8 KB
|
|
|
124 - Limitations.html
|
HTML
|
5.7 KB
|
|
|
125 - Abbreviations.mp4
|
MP4
|
7.5 MB
|
|
|
126 - Abbreviations-Coronavirus.pdf
|
PDF
|
85 KB
|
|
|
126 - Abbreviations.html
|
HTML
|
1.7 KB
|
|
|
127 - The Course Articles Part One.mp4
|
MP4
|
55.9 MB
|
|
|
128 - The Course Articles Part Two.mp4
|
MP4
|
49 MB
|
|
|
129 - The Course Articles Part Three.mp4
|
MP4
|
48.8 MB
|
|
|
13 - Maram Shtaya Approach.mp4
|
MP4
|
77.9 MB
|
|
|
13 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
130 - Curriculum of the Course.mp4
|
MP4
|
12.2 MB
|
|
|
131 - Resources of Course Material.mp4
|
MP4
|
56 MB
|
|
|
131 - Resources-Coronavirus-Story-Perception.pdf
|
PDF
|
350.1 KB
|
|
|
132 - Bonus Lecture with Updated Discount Coupons.html
|
HTML
|
13.8 KB
|
|
|
14 - Maram Shtaya Approach.html
|
HTML
|
3.3 KB
|
|
|
14 - Maram-Shtaya-Approach-Coronavirus-Story.pdf
|
PDF
|
137.7 KB
|
|
|
14 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
15 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
15 - Significance of Maram Shtaya Approach.mp4
|
MP4
|
16.3 MB
|
|
|
16 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
16 - Significance of Maram Shtaya Approach.html
|
HTML
|
3.4 KB
|
|
|
16 - Significance-of-Maram-Shtaya-Approach-Coronavirus-Sory.pdf
|
PDF
|
128.7 KB
|
|
|
17 - 1 Transtheoretical Model TTM.mp4
|
MP4
|
48.6 MB
|
|
|
17 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
18 - 1 Transtheoretical Model TTM.html
|
HTML
|
3.2 KB
|
|
|
18 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
18 - Transtheoretical-Model-Coronavirus-Story.pdf
|
PDF
|
137.7 KB
|
|
|
19 - The Four Structures of the TTM.mp4
|
MP4
|
16.3 MB
|
|
|
2 - Background of the Course.html
|
HTML
|
6.2 KB
|
|
|
2 - Background-of-the-Course-Coronavirus-Story.pdf
|
PDF
|
142.5 KB
|
|
|
2 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
20 - The Four Structures of the TTM.html
|
HTML
|
3.4 KB
|
|
|
20 - The-Four-Structures-of-the-TTM-Coronavirus-Story.pdf
|
PDF
|
128.4 KB
|
|
|
21 - 2 Protection Motivation Theory PMT.mp4
|
MP4
|
6.1 MB
|
|
|
22 - 2 Protection Motivation Theory PMT.html
|
HTML
|
1.9 KB
|
|
|
22 - Protection-Motivation-Theory-Coronavirus-Story.pdf
|
PDF
|
125.4 KB
|
|
|
23 - The Structure of Protection Motivation Theory PMT.mp4
|
MP4
|
9.3 MB
|
|
|
24 - The Structure of Protection Motivation Theory PMT.html
|
HTML
|
2.2 KB
|
|
|
24 - The-Structure-of-Protection-Motivation-Theory-Coronavirus-Story.pdf
|
PDF
|
167.9 KB
|
|
|
25 - 3 KAP Survey Model.mp4
|
MP4
|
24.1 MB
|
|
|
26 - 3 KAP Survey Model.html
|
HTML
|
1.3 KB
|
|
|
26 - KAP-Survey-Model-Coronavirus-Story.pdf
|
PDF
|
134.2 KB
|
|
|
27 - 4 Communication Theory.mp4
|
MP4
|
7.6 MB
|
|
|
28 - 4 Communication Theory.html
|
HTML
|
2.8 KB
|
|
|
28 - Communication-Theory-Coronavirus-Story.pdf
|
PDF
|
134.9 KB
|
|
|
29 - 5 Normalisation Process Theory NPT.mp4
|
MP4
|
9.1 MB
|
|
|
3 - Literature Review.mp4
|
MP4
|
19.6 MB
|
|
|
3 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
30 - 5 Normalisation Process Theory NPT.html
|
HTML
|
2.3 KB
|
|
|
30 - Normalisation-Process-Theory-Coronavirus-Story.pdf
|
PDF
|
127.2 KB
|
|
|
31 - The Normalisation Process Theory NPT Prime Elements.mp4
|
MP4
|
7.6 MB
|
|
|
32 - The Normalisation Process Theory NPT Prime Elements.html
|
HTML
|
1.9 KB
|
|
|
32 - The-Normalisation-Process-Theory-Coronavirus-Story.pdf
|
PDF
|
83.7 KB
|
|
|
33 - 6 Holism Theory.mp4
|
MP4
|
9.1 MB
|
|
|
34 - 6 Holism Theory.html
|
HTML
|
1.8 KB
|
|
|
34 - Holism-Theory-Coronavirus-Story.pdf
|
PDF
|
125.5 KB
|
|
|
35 - 7 Complexity Theory.mp4
|
MP4
|
4.8 MB
|
|
|
36 - 7 Complexity Theory.html
|
HTML
|
1.7 KB
|
|
|
36 - Complexity-Theory-Coronavirus-Story.pdf
|
PDF
|
125 KB
|
|
|
37 - Coronavirus Expression.mp4
|
MP4
|
64.4 MB
|
|
|
38 - Coronavirus Expression.html
|
HTML
|
3.6 KB
|
|
|
38 - Coronavirus-Expression-Coronavirus-Story.pdf
|
PDF
|
143 KB
|
|
|
39 - The Four Coronavirus Genera.mp4
|
MP4
|
10.6 MB
|
|
|
4 - Literature Review.html
|
HTML
|
6.9 KB
|
|
|
4 - Literature-Review-Coronavirus-Story.pdf
|
PDF
|
152.5 KB
|
|
|
4 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
40 - The Four Coronavirus Genera.html
|
HTML
|
2.7 KB
|
|
|
40 - The-Four-Coronavirus-Genera-Coonavirus-Story.pdf
|
PDF
|
136.6 KB
|
|
|
41 - Severe Acute Respiratory Syndrome Coronavirus SARSCoV.mp4
|
MP4
|
25.7 MB
|
|
|
42 - Severe Acute Respiratory Syndrome Coronavirus SARSCoV.html
|
HTML
|
1.9 KB
|
|
|
42 - Severe-Acute-Respiratory-Syndrome-Coronavirus-Coronavirus-Story.pdf
|
PDF
|
83.8 KB
|
|
|
43 - Middle East Respiratory Syndrome Coronavirus MERSCoV.mp4
|
MP4
|
6.2 MB
|
|
|
44 - Middle East Respiratory Syndrome Coronavirus MERSCoV.html
|
HTML
|
2.1 KB
|
|
|
44 - Middle-East-Respiratory-Syndrome-Coronavirus-Coronavirus-Story.pdf
|
PDF
|
127.2 KB
|
|
|
45 - The Coronavirus Genome and Structure.mp4
|
MP4
|
7.2 MB
|
|
|
46 - The Coronavirus Genome and Structure.html
|
HTML
|
1.9 KB
|
|
|
46 - The-Coronavirus-Genome-and-Structure-Coronavirus-Story.pdf
|
PDF
|
125.4 KB
|
|
|
47 - The Epidemiologic Coronavirus Realization.mp4
|
MP4
|
40.7 MB
|
|
|
48 - The Epidemiologic Coronavirus Realization.html
|
HTML
|
2.4 KB
|
|
|
48 - The-Epidemiologic-Coronavirus-Realization-Coronavirus-Story.pdf
|
PDF
|
127.5 KB
|
|
|
49 - Coronavirus Expansion A Central Worry.mp4
|
MP4
|
13.2 MB
|
|
|
5 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
5 - Statement of the Problem and Rational of the Course.mp4
|
MP4
|
20.3 MB
|
|
|
50 - Coronavirus Expansion A Central Worry.html
|
HTML
|
3.5 KB
|
|
|
50 - Coronavirus-Expansion-Coronavirus-Story.pdf
|
PDF
|
141.3 KB
|
|
|
51 - Coronavirus Phylogenetics and Taxonomy Alphacoronavirus.mp4
|
MP4
|
9.9 MB
|
|
|
52 - Coronavirus Phylogenetics and Taxonomy Alphacoronavirus.html
|
HTML
|
2.6 KB
|
|
|
52 - Coronavirus-Phylogenetics-and-Taxonomy-Alphacoronavirus-Coronavirus-Story.pdf
|
PDF
|
127.6 KB
|
|
|
53 - Coronavirus Phylogenetics and Taxonomy – Betacoronavirus Part One.mp4
|
MP4
|
9.2 MB
|
|
|
54 - Coronavirus Phylogenetics and Taxonomy – Betacoronavirus Part One.html
|
HTML
|
2.7 KB
|
|
|
54 - Coronavirus-Phylogenetics-and-Taxonomy-Betacoronavirus-1-Coronavirus-Story.pdf
|
PDF
|
128.4 KB
|
|
|
55 - Coronavirus Phylogenetics and Taxonomy – Betacoronavirus Part Two.mp4
|
MP4
|
13 MB
|
|
|
56 - Coronavirus Phylogenetics and Taxonomy – Betacoronavirus Part Two.html
|
HTML
|
2.9 KB
|
|
|
56 - Coronavirus-Phylogenetics-and-Taxonomy-Betacoronavirus-2-Coronavirus-Story.pdf
|
PDF
|
170.8 KB
|
|
|
57 - Coronavirus Pathogenesis.mp4
|
MP4
|
56.7 MB
|
|
|
58 - Coronavirus Pathogenesis.html
|
HTML
|
3.4 KB
|
|
|
58 - Coronavirus-Pathogenesis-Coronavirus-Story.pdf
|
PDF
|
142 KB
|
|
|
59 - Coronavirus Proteins Receptor Interaction Incorporation and Entrance.mp4
|
MP4
|
10.4 MB
|
|
|
6 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
6 - Statement of the Problem and Rational of the Course.html
|
HTML
|
3.2 KB
|
|
|
6 - Statement-of-the-Problem-and-Rational-of-the-Course-Coronavirus-Story.pdf
|
PDF
|
85.4 KB
|
|
|
60 - Coronavirus Proteins Receptor Interaction Incorporation and Entrance.html
|
HTML
|
3.3 KB
|
|
|
60 - Coronavirus-Proteins-Coronavirus-Story.pdf
|
PDF
|
128.5 KB
|
|
|
61 - Acute Respiratory Tract Contagions.mp4
|
MP4
|
63.8 MB
|
|
|
62 - Acute Respiratory Tract Contagions.html
|
HTML
|
4.2 KB
|
|
|
62 - Acute-Respiratory-Tract-Contagions-Coronavirus-Story.pdf
|
PDF
|
246.2 KB
|
|
|
63 - An Essential Reason of Pneumonia.mp4
|
MP4
|
10.5 MB
|
|
|
64 - An Essential Reason of Pneumonia.html
|
HTML
|
2.7 KB
|
|
|
64 - An-Essential-Reason-of-Pneumonia-Coronavirus-Story.pdf
|
PDF
|
137.6 KB
|
|
|
65 - Hypoxaemia and Acute Respiratory Distress Syndrome ARDS.mp4
|
MP4
|
6.4 MB
|
|
|
66 - Hypoxaemia and Acute Respiratory Distress Syndrome ARDS.html
|
HTML
|
2.3 KB
|
|
|
66 - Hypoxaemia-and-Acute-Respiratory-Distress-Syndrome-Coronavirus-Story.pdf
|
PDF
|
127.5 KB
|
|
|
67 - Coronaviruses CoVs Effects on Humans and Animals.mp4
|
MP4
|
65.9 MB
|
|
|
68 - Coronaviruses CoVs Effects on Humans and Animals.html
|
HTML
|
4.2 KB
|
|
|
68 - Coronaviruses-Effects-on-Humans-and-Animals-Coronavirus-Story.pdf
|
PDF
|
131.1 KB
|
|
|
69 - Urbanization Consequences.mp4
|
MP4
|
12.5 MB
|
|
|
7 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
7 - Objectives of the Course.mp4
|
MP4
|
120.5 MB
|
|
|
70 - Urbanization Consequences.html
|
HTML
|
3.8 KB
|
|
|
70 - Urbanization-Consequences-Coronavirus-Story.pdf
|
PDF
|
137.8 KB
|
|
|
71 - Coronavirus Control Procedures.mp4
|
MP4
|
45.4 MB
|
|
|
72 - Coronavirus Control Procedures.html
|
HTML
|
2.7 KB
|
|
|
72 - Coronavirus-Control-Procedures-Coronavirus-Story.pdf
|
PDF
|
136 KB
|
|
|
73 - After Exposure to Somebody Who has COVID19.mp4
|
MP4
|
13.7 MB
|
|
|
74 - After Exposure to Somebody Who has COVID19.html
|
HTML
|
3.2 KB
|
|
|
74 - After-Exposure-to-Somebody-Who-has-COVID-19-Coronavirus-Story.pdf
|
PDF
|
142.5 KB
|
|
|
75 - SARS‑CoV‑2 Virus and COVID19 Disease.mp4
|
MP4
|
39.8 MB
|
|
|
76 - SARS-CoV-2-Virus-and-COVID-19-Disease-Coronavirus-Story.pdf
|
PDF
|
152 KB
|
|
|
76 - SARS‑CoV‑2 Virus and COVID19 Disease.html
|
HTML
|
3 KB
|
|
|
77 - COVID19 Symptoms.mp4
|
MP4
|
15.1 MB
|
|
|
78 - COVID-19-Symptoms-Coronavirus-Story.pdf
|
PDF
|
244.8 KB
|
|
|
78 - COVID19 Symptoms.html
|
HTML
|
3.6 KB
|
|
|
79 - Procalcitonin A BacteriaParticular Biomarker.mp4
|
MP4
|
23.8 MB
|
|
|
8 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
8 - Objectives of the Course.html
|
HTML
|
4.5 KB
|
|
|
8 - Objectives-of-the-Course-Coronavirus-Story.pdf
|
PDF
|
136.2 KB
|
|
|
80 - Procalcitonin A BacteriaParticular Biomarker.html
|
HTML
|
1.7 KB
|
|
|
80 - Procalcitonin-Coronavirus-Story.pdf
|
PDF
|
125.2 KB
|
|
|
81 - Antibody Responses to SARSCoV2 A Pivotal Concern.mp4
|
MP4
|
12.1 MB
|
|
|
82 - Antibody Responses to SARSCoV2 A Pivotal Concern.html
|
HTML
|
3.7 KB
|
|
|
82 - Antibody-Responses-to-SARS-CoV-2-Coronavirus-Story.pdf
|
PDF
|
129.5 KB
|
|
|
83 - Suggestions Concerning Health Communication.mp4
|
MP4
|
12.3 MB
|
|
|
84 - Suggestions Concerning Health Communication.html
|
HTML
|
2.6 KB
|
|
|
84 - Suggestions-Concerning-Health-Communication-Coronavirus-story.pdf
|
PDF
|
143.4 KB
|
|
|
85 - Nutrition A Determinant Agent for Homeostasis.mp4
|
MP4
|
65.1 MB
|
|
|
86 - Nutrition A Determinant Agent for Homeostasis.html
|
HTML
|
3.8 KB
|
|
|
86 - Nutrition-Coronavirus-Stroy.pdf
|
PDF
|
136.4 KB
|
|
|
87 - Some of Probable Therapeutics for Patients with Coronavirus.mp4
|
MP4
|
10.3 MB
|
|
|
88 - Some of Probable Therapeutics for Patients with Coronavirus.html
|
HTML
|
3.9 KB
|
|
|
88 - Some-of-Probable-Therapeutics-for-Patients-with-Coronavirus-Coronavirus-Story.pdf
|
PDF
|
139.3 KB
|
|
|
89 - Pharmacological Treatment 1 Antimicrobials Usage in Covid19 Patients.mp4
|
MP4
|
13.4 MB
|
|
|
9 - Course Questions.mp4
|
MP4
|
22.6 MB
|
|
|
9 - Multiple Choice.html
|
HTML
|
0 B
|
|
|
90 - Antimicrobials-Usage-in-Covid-19-Coronavirus-Story.pdf
|
PDF
|
140.4 KB
|
|
|
90 - Pharmacological Treatment 1 Antimicrobials Usage in Covid19 Patients.html
|
HTML
|
4.5 KB
|
|
|
91 - 2 Corticosteroid Usage in Patients with Coronavirus.mp4
|
MP4
|
15.8 MB
|
|
|
92 - 2 Corticosteroid Usage in Patients with Coronavirus.html
|
HTML
|
4.8 KB
|
|
|
92 - Corticosteroid-Usage-in-Patients-with-Coronavirus-Coronavirus-Story.pdf
|
PDF
|
140.8 KB
|
|
|
93 - 3 Antimalarial and Antiviral Agents Use in Covid19 Patients.mp4
|
MP4
|
9.2 MB
|
|
|
94 - 3 Antimalarial and Antiviral Agents Use in Covid19 Patients.html
|
HTML
|
2.5 KB
|
|
|
94 - Antimalarial-and-Antiviral-Agents-Use-in-Covid-19-Coronavirus-Story.pdf
|
PDF
|
127.8 KB
|
|
|
95 - 4 Nacetylcysteine Usage in Covid19 Patients.mp4
|
MP4
|
37 MB
|
|
|
96 - 4 Nacetylcysteine Usage in Covid19 Patients.html
|
HTML
|
1.9 KB
|
|
|
96 - N-acetylcysteine-Usage-in-Covid-19-Patients-Coronavirus-Story.pdf
|
PDF
|
126 KB
|
|
|
97 - 5 Anticoagulants and COVID19 Biomarkers – Part One.mp4
|
MP4
|
13.1 MB
|
|
|
98 - 5 Anticoagulants and COVID19 Biomarkers – Part One.html
|
HTML
|
3.5 KB
|
|
|
98 - Anticoagulants-and-COVID-19-Biomarkers.pdf
|
PDF
|
129.2 KB
|
|
|
99 - 5 Anticoagulants and COVID19 Biomarkers – Part Two.mp4
|
MP4
|
11 MB
|
|
|
Bonus Resources.txt
|
TXT
|
409.6 B
|
|
|
Get Bonus Downloads Here.url
|
URL
|
204.8 B
|
